Lung Cancer Genetics Study Launches Open-Source Data
SAN FRANCISCO, Sept. 06, 2025 (GLOBE NEWSWIRE) — 23andMe Research Institute, Troper Wojcicki Philanthropies (TWP), and Lifebit today…
WOW! Achieves 100,000 Fiber Homes Passed Milestone in Greenfield Markets
Continued execution of WOW!’s broadband-first strategy drives rapid growth across new, high-demand communities ENGLEWOOD, Colo., Sept. 4, 2025…
How to land a remote job in a competitive market
NEW YORK (AP) — When Kate Smith worked a 9-to-5 office job, she was burned-out, suffering from daily…
‘Tomb Raider’ show reveals Sophie Turner will play Lara Croft
Sophie Turner can’t help but curse as she recalls her pregnancies Sophie Turner and director Carlson Young chat…
Lee Corso book, farewell page print to celebrate soul of college football
From Brutus to Brutus. With elephants, ducks, steers, tigers (of all stripes), gators and bulldogs in between. Lee…
Foresight Diagnostics and Roche Enter Licensing Agreement for PhasED-Seq™ Technology in Non-Hodgkin’s Lymphoma
The Agreement Closes the Litigation Between the Parties BOULDER, Colo., Aug. 29, 2025 /PRNewswire/ — Foresight Diagnostics (“Foresight”) today…
Baidu-Backed Kunlunxin Lands $139M AI Chip Deal Amid China’s Nvidia Pivot
Baidu, Inc. (NASDAQ:BIDU) is one of the best very cheap stocks to buy according to hedge funds. On…
Online age checks driving concerns they curtail internet freedoms
Online age checks are on the rise in the U.S. and elsewhere, asking people for IDs or face…
Relay Therapeutics to Participate in Two Upcoming Investor
CAMBRIDGE, Mass., Aug. 28, 2025 (GLOBE NEWSWIRE) — Relay Therapeutics, Inc. (Nasdaq: RLAY), a clinical-stage, small molecule precision…
Wall Street edges higher and notches another record for S&P 500
Modest gains on Wall Street lifted the stock market to an all-time high Wednesday ahead of a highly…
Nvidia to report quarterly earnings
SAN FRANCISCO (AP) — Artificial intelligence bellwether Nvidia is poised to release a quarterly report that’s expected provide…
BioXcel Therapeutics To Announce Topline Results from SERENITY At-Home Pivotal Phase 3 Safety Trial for Acute Treatment of Agitation Associated with Bipolar Disorders or Schizophrenia on August 27, 2025
BioXcel Therapeutics Company to host conference call at 8 a.m. ET, August 27, 2025 NEW HAVEN, Conn., Aug.…